CRXX: Summary for CombinatoRx, Incorporated - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:45am EST - Canadian Markets open in 3 hours and 45 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

CombinatoRx, Incorporated (CRXX)

On Feb 9: 1.18 USD 0.00 (0.00%)

MORE ON CRXX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

CombinatoRx, Incorporated (NGM:CRXX) Delayed quote data

Last Trade:	1.18 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.18
Open:	N/A
Bid:	0.91 x 200
Ask:	2.94 x 200
1y Target Est:	1.00

Day's Range:	N/A - N/A
52wk Range:	0.41 - 2.60
Volume:	0
Avg Vol (3m):	1,221,740
Market Cap:	41.31M
P/E (ttm):	N/A
EPS (ttm):	-0.72
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add CRXX to Portfolio

Download Data

HEADLINES

•	Stephen Simpson Of Northland Securities Picks 4 Health Care Stock Winners For 2010
	Wall Street Transcript (Wed, Jan 27)

•	CombinatoRx dangles incentives for new CEO
	at bizjournals.com (Wed, Jan 20)

•	COMBINATORX, INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits
	EDGAR Online (Wed, Jan 20)

•	CombinatoRx reassigns new CEO, COO steps down
	at bizjournals.com (Wed, Jan 6)

•	CombinatoRx Announces Senior Management Team Changes
	Business Wire (Wed, Jan 6)

•	COMBINATORX, INC Files SEC form 8-K, Other Events
	EDGAR Online (Mon, Jan 4)

•	COMBINATORX, INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Material Modification to R
	EDGAR Online (Tue, Dec 22)

•	CombinatoRx closes deal with Neuromed
	at bizjournals.com (Tue, Dec 22)

•	COMBINATORX, INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Material Modification to Rig
	EDGAR Online (Mon, Dec 21)

•	CombinatoRx and Neuromed Close Merger
	Business Wire (Mon, Dec 21)

More Headlines for CRXX...

ANALYST

EPS Est (next year) (Dec-09) :	N/A
EPS Est (in 2 years) (Dec-10) :	N/A
Avg Rec (current)*:	3.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

CombinatoRx, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and outlicensing synergistic combination pharmaceuticals. It develops novel therapeutics with multi-target mechanisms of action that are built from combina...

Full Company Profile

Add to Portfolio

Email to a Friend

•